Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Eur J Ophthalmol ; 33(5): NP41-NP46, 2023 Sep.
Article in English | MEDLINE | ID: mdl-36314406

ABSTRACT

INTRODUCTION: Ocular involvement due to varicella-zoster virus (VZV) infection includes conjunctivitis, scleritis, keratitis, uveitis, and necrotizing retinitis. Non-necrotizing chorioretinopathy as a late manifestation has been described. CASE REPORT: A 50-year-old immunocompetent man developed herpes zoster ophthalmicus (HZO) in the right V1 dermatome with acute anterior uveitis (AAU) treated with oral valaciclovir and topical steroid and a chalazion in the upper eyelid with associated madarosis. Four months later, he presented recurrence of the AAU and multiple areas of chorioretinal atrophy on fundoscopy. Biopsy of the upper eyelid lesion revealed granulomatous inflammation of the eyelid margin and polymerase chain reaction study (PCR) tested positive for VZV-specific DNA. The iridocyclitis was resolved with oral valaciclovir at maximum doses with minimal choroidal pigmentary changes. DISCUSSION: VZV ophthalmic infection starts by reactivation from the trigeminal ganglion, and it spreads to the isthmus of the pilosebaceous follicles and the epidermis, which can cause involvement of follicle and sebaceous glands. Chorioretinopathy is a rare form of late-onset non-necrotizing herpetic uveitis characterized by atrophic-appearing hypopigmented lesions, the pathogenesis of which is unknown. A direct viral infection or secondary to occlusive choroidal vasculitis is postulated at the level of the choriocapillaris and more recently it has been referred to as "choroidal vitiligo" due to possible involvement of choroidal melanocytes, as occurs in cases of cutaneous vitiligo due to VZV infection.


Subject(s)
Herpes Zoster Ophthalmicus , Iridocyclitis , Retinal Diseases , Uveitis, Anterior , Uveitis , Vitiligo , Male , Humans , Middle Aged , Herpes Zoster Ophthalmicus/complications , Herpes Zoster Ophthalmicus/diagnosis , Herpes Zoster Ophthalmicus/drug therapy , Iridocyclitis/diagnosis , Iridocyclitis/drug therapy , Iridocyclitis/complications , Valacyclovir/therapeutic use , Vitiligo/complications , Herpesvirus 3, Human/genetics , Uveitis/complications , Uveitis, Anterior/diagnosis , Uveitis, Anterior/drug therapy , Uveitis, Anterior/complications , Atrophy , Retinal Diseases/complications , Eyelids
3.
Ocul Immunol Inflamm ; 30(7-8): 1956-1960, 2022.
Article in English | MEDLINE | ID: mdl-33872101

ABSTRACT

PURPOSE: To describe a case of cocaine-induced midline destructive lesions (CIMDL) associated with ocular autoimmune disease.Methods: Observational case report. RESULTS: A 45-year-old man with history of chronic osteolytic sinusitis due to cocaine abuse presented with sudden vision loss in right eye. Ophthalmic examination revealed fixed right mydriasis with extraocular movements limitation and optic disc swelling. Computed tomography showed an orbital infiltrating mass. The diagnosis of orbital-apex syndrome secondary to CIMDL was established. Steroids and antibiotics therapy were started without vision improvement. At 6-months follow-up, a corneal ulcer with characteristics of peripheral ulcerative keratitis (PUK) was evidenced, coinciding with an upper respiratory bacterial infection. CONCLUSIONS: CIMDL and PUK share common pathogenic pathways, with implication of autoimmune factors and exposure to infective antigens. We hypothesized that chronic cocaine use, along with persistent bacterial infection, could have triggered an inflammatory reaction, which contributed to CIMDL development and the appearance of PUK.


Subject(s)
Bacterial Infections , Cocaine , Corneal Ulcer , Humans , Middle Aged , Cocaine/adverse effects , Corneal Ulcer/chemically induced , Corneal Ulcer/diagnosis , Corneal Ulcer/drug therapy
4.
Eur J Ophthalmol ; 32(3): 1547-1554, 2022 May.
Article in English | MEDLINE | ID: mdl-34269103

ABSTRACT

PURPOSE: To describe the clinical and epidemiological characteristics of patients with Vogt-Koyanagi-Harada (VKH) disease in Spain. METHODS: This was a retrospective multicenter analysis of data from VKH patients followed for at least 6 months. The data collected were related to demographics, clinical manifestations, treatments, and complications. RESULTS: Participants were 112 patients (224 eyes), from 13 tertiary referral centers, of mean age 37.5 ± 14.7 years; 83.9% were women. Ethnicities were 61.6% Caucasian and 30.4% Hispanic. The disease was classified as complete in 16.1%, incomplete in 55.4%, and probable in 28.6%. When seen for the first time, the clinical course was acute in 69.6%, recurrent chronic in 15.2%, and chronic in 14.3%. The most frequent treatment was corticosteroids (acute stage 42.2%, maintenance stage 55.6%). The most common complications were cataract (41.1%) and ocular hypertension (16.1%). In most eyes, visual acuity was improved (96.7%) or remained stable at the end of follow up. CONCLUSION: VKH in Spain mostly affects women and presents as incomplete acute stage disease. Visual prognosis is good. Cataract and glaucoma are the two most frequent complications.


Subject(s)
Cataract , Glaucoma , Uveomeningoencephalitic Syndrome , Acute Disease , Adult , Cataract/complications , Female , Glaucoma/complications , Humans , Male , Middle Aged , Retrospective Studies , Spain/epidemiology , Uveomeningoencephalitic Syndrome/diagnosis , Uveomeningoencephalitic Syndrome/drug therapy , Uveomeningoencephalitic Syndrome/epidemiology , Visual Acuity , Young Adult
5.
Curr Eye Res ; 46(8): 1184-1192, 2021 08.
Article in English | MEDLINE | ID: mdl-33349072

ABSTRACT

PURPOSE: To investigate the role of plasma calprotectin in non-infectious uveitis. METHODS: This is an observational both cross-sectional and prospective study. Patients with active non-infectious uveitis were recruited as well as nonuveitic controls. Plasma calprotectin was determined and an ophthalmological examination was performed for both patients and controls. Independent variables possibly influencing levels of plasma calprotectin were recorded and analyzed. Categorical variables were compared by chi-square test (applying correction by continuity if necessary). T-test (or Kruskal-Wallis when appropriate) was used to compare averages. Multiple linear regression analysis was used to assess relationship between plasma calprotectin levels and independent variables. Spearman coefficient was calculated in order to establish correlation between plasma calprotectin and anterior chamber cell grading. Changes in plasma calprotectin levels between the flare beginning and its resolution were determined with mixed model for repeated measures. R software (version 3.6.0) was used to perform the statistical analysis. RESULTS: We included 74 patients and 40 controls in the cross-sectional study. Plasma calprotectin levels were higher in uveitis patients compared to those of controls (p = .003), being higher in younger patients and patients with posterior uveitis. No correlation between calprotectin and anterior chamber inflammation degree was found (p = .198). For the prospective study, we included 36 patients. We found no significant differences in calprotectin levels between active and inactive uveitis (p = .344). CONCLUSIONS: Plasma calprotectin levels are elevated in uveitis patients and are influenced by age and anatomical location of uveitis. Further investigation is needed to assess the relationship between calprotectin and uveitis activity.


Subject(s)
Biomarkers/blood , Leukocyte L1 Antigen Complex/blood , Uveitis/blood , Adult , Aged , Aging/physiology , Cross-Sectional Studies , Female , Fluorescein Angiography , Humans , Male , Middle Aged , Prospective Studies , Slit Lamp Microscopy , Tomography, Optical Coherence , Uveitis/diagnosis , Visual Acuity/physiology
6.
Eur J Ophthalmol ; 31(2): NP97-NP101, 2021 Mar.
Article in English | MEDLINE | ID: mdl-32164465

ABSTRACT

PURPOSE: To report a case of primary choroidal lymphoma that was confirmed by polymerase chain reaction-based clonality testing. CASE REPORT: A 50-year-old woman presented with unilateral progressive vision loss. Fundus examination and B-ultrasonography demonstrated diffuse choroidal thickening without vitritis. Pars plana vitrectomy and subretinal biopsy were performed, and histopathologic analysis revealed choroidal B-cell lymphoid hyperplasia without evidence of neoplasia. Extraocular extension was ruled out, and transitory improvement was observed with oral steroids. After 1-year follow-up, she was referred to our hospital and clonality testing was performed using the samples taken months before. First, we used a forensic DNA extraction kit, and then, a multiplex polymerase chain reaction was carried out using the IgH Rearrangements Molecular Analysis Kit. Clonal rearrangement was identified for the immunoglobulin heavy chain framework regions 1 and 2, and B-cell choroidal lymphoma was confirmed. The patient began treatment with intravitreal rituximab, but no response was observed. Finally, complete regression was achieved using external beam radiotherapy. CONCLUSION: Polymerase chain reaction-based clonality testing can be a valuable tool to confirm a choroidal lymphoproliferative process.


Subject(s)
Choroid Neoplasms/diagnosis , DNA, Neoplasm/genetics , Immunoglobulin Heavy Chains/genetics , Lymphoma, B-Cell/diagnosis , Antineoplastic Agents, Immunological/therapeutic use , Choroid Neoplasms/drug therapy , Choroid Neoplasms/genetics , Choroid Neoplasms/pathology , Female , Humans , Intravitreal Injections , Lymphoma, B-Cell/drug therapy , Lymphoma, B-Cell/genetics , Lymphoma, B-Cell/pathology , Middle Aged , Nucleic Acid Amplification Techniques , Polymerase Chain Reaction , Rituximab/therapeutic use , Ultrasonography
8.
Ocul Immunol Inflamm ; 28(8): 1285-1289, 2020 Nov 16.
Article in English | MEDLINE | ID: mdl-33021422

ABSTRACT

PURPOSE: To describe a case of inflammatory chorioretinopathy and Adie's syndrome possibly associated with COVID-19. METHODS: Observational case report. RESULTS: A 51-year-old woman developed fever, cough, and headache followed by retro-ocular pain and reading impairment. She tested positive for SARS-COV-2 infection by qualitative real-time reverse-transcriptase-polymerase-chain-reaction. The slit-lamp and funduscopic exam revealed abnormal pupillary response and yellowish creamy deep chorioretinal lesions, which were not present in previous examinations. Instillation of pilocarpine demonstrated denervation supersensitivity, and it was suggestive of bilateral Adie tonic pupil. A comprehensive work-up ruled out other systemic, autoimmune, or infectious diseases. CONCLUSIONS: This case illustrates the possible association between multifocal chorioretinitis and Adie's syndrome, and the SARS-COV-2 infection in humans. Further investigation of virus infectivity specifically within ocular tissues has to be conducted.


Subject(s)
Adie Syndrome/etiology , Betacoronavirus , Coronavirus Infections/complications , Pneumonia, Viral/complications , Visual Acuity , Adie Syndrome/diagnosis , COVID-19 , Coronavirus Infections/epidemiology , Female , Fluorescein Angiography , Fundus Oculi , Humans , Middle Aged , Pandemics , Pneumonia, Viral/epidemiology , SARS-CoV-2 , Tomography, Optical Coherence
9.
Biomed Res Int ; 2015: 408180, 2015.
Article in English | MEDLINE | ID: mdl-26618168

ABSTRACT

We have studied the global risk of retinopathy in a Mediterranean population of type 2 diabetes mellitus (T2DM) patients, according to clinical, biochemical, and lifestyle biomarkers. The effects of the oral supplementation containing antioxidants/omega 3 fatty acids (A/ω3) were also evaluated. Suitable participants were distributed into two main groups: (1) T2DMG (with retinopathy (+DR) or without retinopathy (-DR)) and (2) controls (CG). Participants were randomly assigned (+A/ω3) or not (-A/ω3) to the oral supplementation with a daily pill of Nutrof Omega (R) for 18 months. Data collected including demographics, anthropometrics, characteristics/lifestyle, ophthalmic examination (best corrected visual acuity, ocular fundus photographs, and retinal thickness as assessed by optical coherence tomography), and blood parameters (glucose, glycosylated hemoglobin, triglycerides, malondialdehyde, and total antioxidant capacity) were registered, integrated, and statistically processed by the SPSS 15.0 program. Finally, 208 participants (130 diabetics (68 +DR/62 -DR) and 78 controls) completed the follow-up. Blood analyses confirmed that the T2DMG+DR patients had significantly higher oxidative stress (p < 0.05), inflammatory (p < 0.05), and vascular (p < 0.001) risk markers than the T2DMG-DR and the CG. Furthermore, the A/ω3 oral supplementation positively changed the baseline parameters, presumptively by inducing metabolic activation and ameliorating the ocular health after 18 months of supplementation.


Subject(s)
Biomarkers/blood , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/metabolism , Diabetic Retinopathy/blood , Diabetic Retinopathy/physiopathology , Dietary Supplements , Oxidative Stress/drug effects , Adult , Aged , Aged, 80 and over , Antioxidants/metabolism , Blood Glucose/drug effects , Diabetes Mellitus, Type 2/physiopathology , Diabetic Retinopathy/metabolism , Fatty Acids, Omega-3/blood , Female , Glycated Hemoglobin/metabolism , Humans , Male , Malondialdehyde/blood , Middle Aged , Tomography, Optical Coherence/methods , Triglycerides
10.
Exp Eye Res ; 124: 1-10, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24792588

ABSTRACT

Insulin receptor substrate-2 (Irs2) mediates peripheral insulin action and is essential for retinal health. Previous investigations have reported severe photoreceptor degeneration and abnormal visual function in Irs2-deficient mice. However, molecular changes in the Irs2(-)(/)(-) mouse retina have not been described. In this study, we examined retinal degenerative changes in neuronal and glial cells of adult (9- and 12-week old) Irs2(-)(/)(-) mice by immunohistochemistry. 9-week old Irs2(-)(/)(-) mice showed significant thinning of outer retinal layers, concomitant to Müller and microglial cell activation. Photoreceptor cells displayed different signs of degeneration, such as outer/inner segment atrophy, redistribution of rod- and cone-opsins and spatial disorganization of cone cells. This was accompanied by synaptic changes at the outer plexiform layer, including the retraction of rod-spherules, reduction of photoreceptor synaptic ribbons and synaptic remodeling in second order neurons (i.e. loss and sprouting of dendritic processes in rod bipolar and horizontal cells). By 12 weeks of age, the thickness of inner retinal layers was severely affected. Although inner plexiform layer stratification remained unchanged at this stage, rod bipolar cell axon terminals were significantly depleted. Significant loss of Brn3a(+) retinal ganglion cells occurred in 12-week old Irs2(-)(/)(-) mice, in contrast to younger ages. Adult Irs2(-)(/)(-) mice showed clear hallmarks of neurodegeneration and disruption of the inner retina with increasing age. Pharmacological stimulation of Irs2 signaling pathway may provide additional neuroprotection in certain degenerative retinopathies.


Subject(s)
Insulin Receptor Substrate Proteins/metabolism , Photoreceptor Cells, Vertebrate/pathology , Retinal Bipolar Cells/pathology , Retinal Degeneration/pathology , Retinal Ganglion Cells/pathology , Vision, Ocular/physiology , Animals , Disease Models, Animal , Electroretinography , Immunohistochemistry , Mice , Mice, Inbred C57BL , Microscopy, Confocal , Photoreceptor Cells, Vertebrate/metabolism , Retinal Bipolar Cells/metabolism , Retinal Degeneration/metabolism , Retinal Degeneration/physiopathology , Retinal Ganglion Cells/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...